2nd International Workshop On Long Acting Anti-Infectives (LAAI) 2026

What's New

The exact date and location of LAAI 2026 is being confirmed. We will share the updates here shortly!

About this Program

The International Workshop On Long Acting Anti-Infectives (LAAI) is a crucial platform for advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies. This 1st edition of the workshop will explore the transformative potential of LA/ER drug delivery in infectious disease management, with a focus on recent breakthroughs in HIV prevention and treatment.

Attendees will discuss the clinical application of these therapies in populations with historically low adherence, including pediatric patients, pregnant and breastfeeding women, and individuals experiencing homelessness.

By sharing knowledge on trial design, safety, efficacy, and implementation strategies, this 2-day hybrid workshop will contribute to the global effort to improve health outcomes, extending the benefits of these therapies beyond HIV to other infectious diseases like tuberculosis, malaria, and viral hepatitis.